0001104659-16-140127.txt : 20160816 0001104659-16-140127.hdr.sgml : 20160816 20160816203151 ACCESSION NUMBER: 0001104659-16-140127 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160812 FILED AS OF DATE: 20160816 DATE AS OF CHANGE: 20160816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Amphastar Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001297184 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330702205 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11570 SIXTH STREET CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 BUSINESS PHONE: 909-980-9484 MAIL ADDRESS: STREET 1: 11570 SIXTH STREET CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZASLOFF MICHAEL A CENTRAL INDEX KEY: 0001033511 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36509 FILM NUMBER: 161837337 4 1 a4.xml 4 X0306 4 2016-08-12 0 0001297184 Amphastar Pharmaceuticals, Inc. AMPH 0001033511 ZASLOFF MICHAEL A C/O AMPHASTAR PHARMACEUTICALS, INC. 11570 6TH STREET RANCHO CUCAMONGA CA 91730 1 0 0 0 Common Stock 2016-08-12 4 M 0 10381 15.23 A 42792 D Common Stock 2016-08-12 4 M 0 20594 14.23 A 63386 D Common Stock 2016-08-12 4 S 0 30975 18.1157 D 32411 D Common Stock 2016-08-15 4 M 0 17400 14.23 A 49811 D Common Stock 2016-08-15 4 S 0 17400 18.2168 D 32411 D Stock Option (right to buy) 15.23 2016-08-12 4 M 0 10381 0 D 2016-10-03 Common Stock 10381 0 D Stock Option (right to buy) 14.23 2016-08-12 4 M 0 20594 0 D 2016-12-10 Common Stock 20594 17400 D Stock Option (right to buy) 14.23 2016-08-15 4 M 0 17400 0 D 2016-12-10 Common Stock 17400 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.39, inclusive. Shares subject to the option are fully vested and immediately exercisable. /s/ Ken Stupak, by power of attorney 2016-08-15